Search

Search Results
Results 51 - 60 of 60 for Sibutramine
  • 65 percent of America’s adults are overweight and 31 percent of adults are obese and at risk for chronic diseases
    News - 11 Jun 2004
    Government and private sector health experts now estimate that 65 percent of America’s adults are overweight and 31 percent of adults are obese and at risk for chronic diseases such as diabetes and...
  • Zyvox
    Drug - 28 Jan 2024
    Consumer Medicine Information (CMI) about Zyvox intended for persons living in Australia.
  • Obesity Management
    Health - 23 Jan 2023
    Obesity is a major public health problem. It is directly associated with several health conditions including diabetes, heart disease, stroke, hypertension, gallbladder disease and fatty liver disease...
  • High-performance Thin Layer Chromatography (HPTLC) in the Pharmaceutical Industry
    Life Sciences - 17 Oct 2019
    High-performance Thin Layer Chromatography (HPTLC) is a robust and cost-effective separation technique employed in the development and analysis of new drugs.
  • Desvenlafaxine Viatris
    Drug - 4 Nov 2025
    Consumer Medicine Information (CMI) about Desvenlafaxine Viatris intended for persons living in Australia.
  • Desfax
    Drug - 27 Nov 2024
    Consumer Medicine Information (CMI) about Desfax intended for persons living in Australia.
  • Pristiq
    Drug - 28 Jan 2024
    Consumer Medicine Information (CMI) about Pristiq intended for persons living in Australia.
  • Proveblue
    Drug - 27 Oct 2022
    Consumer Medicine Information (CMI) about Proveblue intended for persons living in Australia.
  • Aurorix
    Drug - 21 Mar 2022
    Consumer Medicine Information (CMI) about Aurorix intended for persons living in Australia.
  • Amira 150 and Amira 300
    Drug - 21 Mar 2022
    Consumer Medicine Information (CMI) about Amira 150 and Amira 300 intended for persons living in Australia.

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback